These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19264765)

  • 1. Re-evaluating the efficacy of beta-adrenergic agonists and antagonists in long QT-3 syndrome through computational modelling.
    Ahrens-Nicklas RC; Clancy CE; Christini DJ
    Cardiovasc Res; 2009 Jun; 82(3):439-47. PubMed ID: 19264765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome.
    Shimizu W; Antzelevitch C
    J Am Coll Cardiol; 2000 Mar; 35(3):778-86. PubMed ID: 10716483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular biology of the long QT syndrome: impact on management.
    Priori SG; Napolitano C; Paganini V; Cantù F; Schwartz PJ
    Pacing Clin Electrophysiol; 1997 Aug; 20(8 Pt 2):2052-7. PubMed ID: 9272507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propranolol prevents life-threatening arrhythmias in LQT3 transgenic mice: implications for the clinical management of LQT3 patients.
    Calvillo L; Spazzolini C; Vullo E; Insolia R; Crotti L; Schwartz PJ
    Heart Rhythm; 2014 Jan; 11(1):126-32. PubMed ID: 24135497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A molecular basis for the therapy of the long QT syndrome.
    Priori SG; Napolitano C; Schwartz PJ
    Arch Mal Coeur Vaiss; 1996 Sep; 89(9):1185-7. PubMed ID: 8952843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular basis for the ECG features of the LQT1 form of the long-QT syndrome: effects of beta-adrenergic agonists and antagonists and sodium channel blockers on transmural dispersion of repolarization and torsade de pointes.
    Shimizu W; Antzelevitch C
    Circulation; 1998 Nov; 98(21):2314-22. PubMed ID: 9826320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autonomic modulation and antiarrhythmic therapy in a model of long QT syndrome type 3.
    Fabritz L; Damke D; Emmerich M; Kaufmann SG; Theis K; Blana A; Fortmüller L; Laakmann S; Hermann S; Aleynichenko E; Steinfurt J; Volkery D; Riemann B; Kirchhefer U; Franz MR; Breithardt G; Carmeliet E; Schäfers M; Maier SK; Carmeliet P; Kirchhof P
    Cardiovasc Res; 2010 Jul; 87(1):60-72. PubMed ID: 20110334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific therapy based on the genotype and cellular mechanism in inherited cardiac arrhythmias. Long QT syndrome and Brugada syndrome.
    Shimizu W; Aiba T; Antzelevitch C
    Curr Pharm Des; 2005; 11(12):1561-72. PubMed ID: 15892662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular basis for long QT, transmural dispersion of repolarization, and torsade de pointes in the long QT syndrome.
    Shimizu W; Antzelevitch C
    J Electrocardiol; 1999; 32 Suppl():177-84. PubMed ID: 10688323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing torsade des pointes in LQT2 and LQT3 models of the long-QT syndrome.
    Shimizu W; Antzelevitch C
    Circulation; 1997 Sep; 96(6):2038-47. PubMed ID: 9323097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting the β-adrenergic receptor in the clinical management of congenital long QT syndrome.
    Saadeh K; Shivkumar K; Jeevaratnam K
    Ann N Y Acad Sci; 2020 Aug; 1474(1):27-46. PubMed ID: 32901453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic vs. pro-arrhythmic effects depending on the intensity of adrenergic stimulation in a canine anthopleurin-A model of type-3 long QT syndrome.
    Chinushi M; Izumi D; Iijima K; Ahara S; Komura S; Furushima H; Hosaka Y; Aizawa Y
    Europace; 2008 Feb; 10(2):249-55. PubMed ID: 18256131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of epinephrine, propranolol, and atrial pacing on spatial distribution of recovery time measured by body surface mapping in congenital long QT syndrome.
    Shimizu W; Kamakura S; Kurita T; Suyama K; Aihara N; Shimomura K
    J Cardiovasc Electrophysiol; 1997 Oct; 8(10):1102-14. PubMed ID: 9363813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of asthma in children with long QT syndrome.
    Collins S; Widger J; Davis A; Massie J
    Paediatr Respir Rev; 2012 Jun; 13(2):100-5. PubMed ID: 22475256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent torsade de pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome.
    Shimizu W; Antzelevitch C
    Circulation; 2000 Aug; 102(6):706-12. PubMed ID: 10931813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mexiletine Shortens the QT Interval in Patients With Potassium Channel-Mediated Type 2 Long QT Syndrome.
    Bos JM; Crotti L; Rohatgi RK; Castelletti S; Dagradi F; Schwartz PJ; Ackerman MJ
    Circ Arrhythm Electrophysiol; 2019 May; 12(5):e007280. PubMed ID: 31006312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypernatremia and intercalated disc edema synergistically exacerbate long-QT syndrome type 3 phenotype.
    Wu X; Hoeker GS; Blair GA; King DR; Gourdie RG; Weinberg SH; Poelzing S
    Am J Physiol Heart Circ Physiol; 2021 Dec; 321(6):H1042-H1055. PubMed ID: 34623182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of different beta-blockers in the treatment of long QT syndrome.
    Abu-Zeitone A; Peterson DR; Polonsky B; McNitt S; Moss AJ
    J Am Coll Cardiol; 2014 Sep; 64(13):1352-8. PubMed ID: 25257637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sodium channel block with mexiletine to reverse action potential prolongation in in vitro models of the long term QT syndrome.
    Sicouri S; Antzelevitch D; Heilmann C; Antzelevitch C
    J Cardiovasc Electrophysiol; 1997 Nov; 8(11):1280-90. PubMed ID: 9395171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of verapamil and propranolol on early afterdepolarizations and ventricular arrhythmias induced by epinephrine in congenital long QT syndrome.
    Shimizu W; Ohe T; Kurita T; Kawade M; Arakaki Y; Aihara N; Kamakura S; Kamiya T; Shimomura K
    J Am Coll Cardiol; 1995 Nov; 26(5):1299-309. PubMed ID: 7594047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.